Concepedia

Publication | Open Access

Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US

DOIFull Paper Access

83

Citations

31

References

2018

Year

Kristen M. Krysko, Jennifer Graves, Mary Rensel, Bianca Weinstock‐Guttman, Gregory Aaen, Leslie Benson, Tanuja Chitnis, Mark Gorman, Manu S. Goyal, Lauren Krupp,
Neurology

Abstract

Newer DMTs are often used in pediatric MS, and have similar short-term safety, tolerability, and side effect profiles as in adults. These findings may help inform pediatric MS management.

References

YearCitations

Page 1